1. Home
  2. TRMK vs HAE Comparison

TRMK vs HAE Comparison

Compare TRMK & HAE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Trustmark Corporation

TRMK

Trustmark Corporation

HOLD

Current Price

$44.40

Market Cap

2.5B

Sector

Finance

ML Signal

HOLD

Logo Haemonetics Corporation

HAE

Haemonetics Corporation

HOLD

Current Price

$59.78

Market Cap

2.8B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
TRMK
HAE
Founded
1889
1971
Country
United States
United States
Employees
N/A
3023
Industry
Major Banks
Medical/Dental Instruments
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
2.5B
2.8B
IPO Year
1994
1996

Fundamental Metrics

Financial Performance
Metric
TRMK
HAE
Price
$44.40
$59.78
Analyst Decision
Hold
Buy
Analyst Count
2
9
Target Price
$44.50
$84.13
AVG Volume (30 Days)
309.5K
610.0K
Earning Date
04-28-2026
05-07-2026
Dividend Yield
2.23%
N/A
EPS Growth
1.93
44.54
EPS
3.70
2.46
Revenue
N/A
$910,373,000.00
Revenue This Year
$9.82
N/A
Revenue Next Year
$4.86
$5.23
P/E Ratio
$12.12
$24.14
Revenue Growth
N/A
N/A
52 Week Low
$33.09
$47.32
52 Week High
$45.82
$87.32

Technical Indicators

Market Signals
Indicator
TRMK
HAE
Relative Strength Index (RSI) 55.33 50.01
Support Level $43.39 $48.47
Resistance Level $45.43 $62.78
Average True Range (ATR) 0.86 1.93
MACD -0.01 0.26
Stochastic Oscillator 51.50 51.06

Price Performance

Historical Comparison
TRMK
HAE

About TRMK Trustmark Corporation

Trustmark Corp is a bank holding company. Through its subsidiaries, the company operates as a financial services organization providing banking and other financial solutions in Alabama, Florida, Mississippi, Tennessee, and Texas. Its principal products and services include Commercial Banking, Consumer Banking, Mortgage Banking, Insurance, Wealth Management and Trust Services, and others. The company is managed along two operating segments: General Banking and Wealth Management. The General Banking segment, which generates the majority of the revenue, provides all traditional banking products and services, including loan deposits, and also consists of internal operations.

About HAE Haemonetics Corporation

Haemonetics Corp aims to improve patient care and reduce the cost of healthcare by providing medical products and solutions in the blood and plasma component collection, surgical suite, and hospital transfusion service spaces. As such, the company operates under three segments: plasma, blood center, and hospital. The company primarily emphasizes its plasma and hospital segments due to their robust growth potential, whereas the blood center segment tends to be constrained by higher competition. Product revenue is driven by demand for disposable blood component collection and processing sets and the related equipment needed for proper functionality.

Share on Social Networks: